🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Consumer Staples Sector SEC Filings — August 03, 2026

The Consumer Staples sector is showing a clear divergence between defensive growth and inflationary pressure. Clorox's Q4 FY26 earnings reveal significant acquisition-driven revenue growth (GOJO added ~10 points) but severe margin compression (-520 bps gross margin) and declining organic sales, pointing to a challenging operating environment. Insider activity is mixed but notable: Coca-Cola's CFO executed a large $13.3M sale (albeit after a pre-planned option exercise), while Hershey's 10% owner sold ~$1.15M under a 10b5-1 plan, signaling potential caution from key stakeholders. In contrast, Church & Dwight and McCormick are awarding phantom stock to executives, a neutral-to-slightly-bullish retention signal. The sector is experiencing a 'growth through M&A' theme, but the cost of integration and persistent inflation are eroding profitability. The delisting of matured debt for Philip Morris and Procter & Gamble is a non-event, confirming routine capital management. The key takeaway is that while top-line growth is achievable via M&A, organic volume and margin health remain under severe pressure, making stock selection critical.

9 high priority 1 medium 10 total filings
· daily

S&P 500 Industrials Sector SEC Filings — August 03, 2026

The seven filings for August 3, 2026, are exclusively from Honeywell International Inc. and its subsidiary, Honeywell Aerospace Inc., plus one from Republic Services, Inc. The dominant theme is a wave of insider transactions at Honeywell, characterized by the routine exercise and tax-withholding of restricted stock units (RSUs) by senior executives, including the CFO and the President/CEO of a key division. This pattern is typical of scheduled vesting events and does not signal a bearish shift in management sentiment. However, one notable outlier is a direct open-market sale by the President/CEO of Process Technologies, which warrants closer attention for potential conviction change. The Republic Services filing shows a director exercising RSUs, a standard non-cash event. The digest lacks period-over-period financial comparisons, forward-looking guidance, or capital allocation data, limiting the ability to identify broader sector trends. The primary actionable intelligence is the need to monitor Honeywell's upcoming earnings call for commentary on the Process Technologies division and to track any acceleration in insider selling across the broader industrial sector.

7 high priority 7 total filings
· daily

Insider Trading Pulse — August 03, 2026

The August 3, 2026 insider trading digest reveals a market with divergent signals: significant insider buying by directors at beaten-down consumer and industrial names (HARLEY-DAVIDSON, Goosehead Insurance) signals deep value conviction, while substantial CEO and CFO sales at Super Group (SGHC) and a $1M+ sale by NUCOR's COO raise caution flags in the gaming and materials sectors. The day is dominated by neutral, non-discretionary transactions (awards, tax withholdings, option exercises) across 50 filings, but the high-conviction open-market purchases and sales provide the strongest actionable signals. A notable cluster of insider buying in financials (SHENANDOAH TELECOMMUNICATIONS, COLONY BANKCORP, FARMERS & MERCHANTS BANCORP) suggests a contrarian bet on regional banks and small-cap value. The most bearish signal is the coordinated selling by Super Group's CEO and CFO on the same day, totaling nearly $1M, which warrants close scrutiny of the company's fundamentals. Overall, the data points to a cautious but opportunistic insider community, with capital being deployed into deep-value plays while profit-taking occurs in high-flying names.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — August 03, 2026

The August 3, 2026 digest for the Dow Jones 30 reveals a stark divergence between the industrial and financial sectors. Goldman Sachs delivered a standout quarter, with net revenues surging 39% YoY to $20.3B, driven by a 61% jump in Investment Banking and Market Making, while net earnings more than doubled to $6.4B, signaling robust capital markets activity. In contrast, the insider trading patterns across Honeywell International and its subsidiary, Honeywell Aerospace, present a mixed picture: while routine tax-withholding sales by senior executives are neutral, a direct sale by the President/CEO of Process Technologies for $77.6K at a recent high price introduces a bearish signal. The most significant negative signal comes from Coca-Cola, where the President and CFO executed a large, fully disclosed sale of $13.3M in stock after exercising options, a transaction that often raises concerns about valuation or internal outlook. A routine debt delisting for Procter & Gamble is a non-event. The overarching theme is one of financial sector strength versus potential caution signals from industrial and consumer staples leadership, with Goldman Sachs' explosive growth being the dominant, actionable catalyst.

9 high priority 9 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — August 03, 2026

Hughes Satellite Systems Corp and certain U.S. subsidiaries have filed for Chapter 11 bankruptcy in the Southern District of Texas, marking a significant corporate distress event in the satellite communications sector. The filing is driven by the need to restructure maturing secured and unsecured debt, while the company intends to refocus operations on B2B, government, and defense markets. Critically, EchoStar Corporation and Hughes' international subsidiaries are excluded from the filing, and the company has sufficient near-term liquidity to continue serving customers during the process. The filing has no impact on EchoStar's other brands (DISH TV, Sling TV, Boost Mobile), but it signals deep financial strain within the legacy satellite business. The company has engaged White & Case LLP as legal counsel and FTI Consulting as financial advisor, indicating a structured restructuring process. This event underscores the ongoing challenges in the satellite and telecom sector, particularly for companies with high debt loads and maturing obligations.

1 high priority 1 total filings
· daily

Global High-Priority Regulatory Events — August 03, 2026

This digest covers 50 filings from August 3, 2026, dominated by high-stakes corporate events: a major bankruptcy (Sleep Number), a transformative acquisition (Brookfield/Oaktree), and a wave of insolvencies in India (Pradhin, IL&FS, BIL Vyapar). A key theme is the active restructuring of private credit BDCs, with 10+ tender offers providing liquidity but revealing low shareholder participation (7.6%-25.5% take-up). Period-over-period data shows a stark contrast: ONEOK reported strong 13% net income growth and raised guidance, while the acquisition target Light Across saw revenue drop to zero and its auditor issued a going concern opinion. Insider activity is notably absent across most filings, with no officers or directors tendering shares in any of the BDC offers, signaling a lack of conviction in the current NAV. The most actionable opportunities lie in the post-restructuring plays of Sleep Number's asset sale and the Brookfield/Oaktree credit platform, while the highest risks are the cascading Indian insolvencies and the dilutive SPAC merger for Galera/Obsidian.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 03, 2026

Today's filings reveal a market bifurcated between aggressive M&A and capital returns versus deep operational and financial distress. The most significant development is the $3.8B acquisition of Atkore by Prysmian at a 30% premium, alongside a major SPAC IPO by Albatross Acquisition Corp and a massive insider stake buildup in Ellomay Capital. However, these bullish signals are countered by severe red flags: EchoStar's dramatic swing to profit is a one-time accounting gain masking a going concern warning, Braskem is on the brink of judicial reorganization, and Avista faces catastrophic wildfire losses. Financial sector results are robust, with MUFG and Nomura posting strong YoY profit growth, while the semiconductor space sees consolidation via Skyworks' acquisition of Qorvo. Period-over-period trends show a clear divergence: revenue growth is present but often accompanied by margin compression or one-time charges, as seen in Atkore and Nextpower. Insider activity is mixed, with routine PDMR transactions at Diageo and significant shareholder dissent at Palatin Technologies. The overarching theme is a market rewarding strategic consolidation and capital returns while punishing companies with balance sheet or operational weaknesses.

16 high priority 34 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 03, 2026

The five filings from the S&P 500 Consumer Discretionary sector reveal a bifurcated landscape. Marriott International's mixed Q2 2026 results show a resilient U.S. market (RevPAR +5.0% YoY) and strong fee growth (+12.8% YoY), but international weakness (RevPAR -0.5%) and a deteriorating balance sheet (stockholders' deficit worsened to -$4.5B) create a cautious outlook. The company raised full-year RevPAR guidance to 3.0-3.5%, signaling confidence in the domestic recovery. Conversely, insider selling at Yum! Brands (CEO and KFC Division CEO sold small tranches under 10b5-1 plans) and a massive $3.54M sale by GM's EVP suggest management is taking profits or hedging exposure. The most critical development is Marriott's record pipeline of ~629,000 rooms and the shift toward conversions (over 40% of openings), which signals a capital-light growth strategy. Portfolio-level patterns show a clear divergence: asset-light, fee-based models (Marriott's franchise fees +18.9% YoY) are outperforming, while legacy auto and restaurant operators face insider skepticism. The key market implication is that investors should favor companies with strong fee income and domestic exposure over those with international headwinds or heavy insider selling.

4 high priority 1 medium 5 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 03, 2026

The S&P 500 Healthcare sector shows a clear bifurcation in Q2 2026: large-cap pharma (Pfizer, AbbVie, Eli Lilly) are generating strong revenue growth (7-11% YoY) and margin expansion, while medical device and diagnostics firms (Boston Scientific, Danaher) are navigating margin headwinds from reinvestment and M&A. Insider activity is notably bullish at Boston Scientific, with two separate insider purchases totaling ~$3.2M, signaling strong management conviction. The most critical development is Vertex's $1.65B acquisition of Crinetics, which diversifies its pipeline beyond cystic fibrosis but introduces integration risk. Capital allocation patterns show a shift: AbbVie and Boston Scientific are aggressively returning capital via dividends and buybacks ($8.1B combined in H1 2026), while Gilead maintains a strategic investment portfolio of $1.65B in biotech partnerships. The portfolio-level theme is 'growth through innovation and M&A, funded by strong cash flows, but with rising R&D costs pressuring margins.' Danaher's CEO succession is a key governance event to watch, as it signals a strategic pivot toward diagnostics leadership. Overall, the sector is fundamentally healthy but investors should focus on companies with clear catalysts and disciplined capital allocation, avoiding those with deteriorating balance sheets or integration overhang.

8 high priority 2 medium 10 total filings
· daily

US Earnings Financial Results SEC Filings — August 03, 2026

The 50 filings for the period ending August 3, 2026, reveal a market characterized by sharp divergence: a handful of industrial and tech companies (Advanced Energy, Boston Scientific, Electronic Arts) are delivering strong operational leverage and margin expansion, while a larger cohort is experiencing margin compression from rising costs (labor, fuel, interest) despite modest revenue growth. The most significant portfolio-level trend is a surge in non-cash charges (impairments, deconsolidation gains/losses, digital asset revaluations) that are distorting reported net income, making operating cash flow and adjusted metrics more critical than ever. Insider activity is notably absent across the majority of filings, but capital allocation patterns are stark: aggressive share buybacks at Boston Scientific and Marriott are draining cash, while several small-cap biotechs and pre-revenue explorers are burning through cash reserves. The most critical development is the substantial doubt about EchoStar's subsidiaries' ability to continue as a going concern, a high-risk flag for the telecom sector. Overall, the market is rewarding companies with pricing power and cost control, while punishing those with high fixed costs or exposure to volatile input prices.

50 high priority 50 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 03, 2026

The IPO pipeline for August 3, 2026, is dominated by two blank-check companies (SPACs) filing S-1 registrations: GX Acquisition Corp. III and 1776 Acquisition Corp. Both filings are neutral in sentiment and carry a materiality score of 7/10, reflecting the inherently speculative nature of SPACs with no operating history or identified targets. The filings reveal a common theme of limited working capital, with GX Acquisition Corp. III explicitly stating only ~$1.275 million is available outside the trust to fund operations for 24 months, while 1776 Acquisition Corp. emphasizes a 15% over-allotment option and trust account structure. No period-over-period comparisons, insider trading activity, forward-looking guidance, or capital allocation data are available from these initial filings, as both companies are pre-revenue and pre-operational. The key development is the simultaneous registration of two SPACs, signaling continued market appetite for blank-check vehicles despite regulatory scrutiny and redemption risks. The lack of enriched data fields (period comparisons, insider trades, guidance) limits deep quantitative synthesis, but the structural risks—redemption caps, competition, and potential litigation—are actionable for investors monitoring the SPAC space.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — August 03, 2026

The August 3, 2026, batch of 50 filings reveals a significant wave of leadership transitions, with a clear focus on strategic succession planning and board refreshment. A dominant theme is the appointment of seasoned executives with deep industry experience, particularly in financial services and technology, as seen at Danaher, Best Buy, and Cintas. The data shows a strong positive sentiment around these appointments, with several companies like Danaher and Stagwell providing forward-looking guidance that reaffirms their financial outlook. A notable pattern is the coordinated board succession across multiple Invesco ETFs, where Matthew Casaccia replaced Jordan Krugman on 12 different fund boards, indicating a routine but widespread governance change. While most transitions are orderly, the CFO resignation at W.W. Grainger and the CEO removal at Amaze Holdings stand out as higher-risk events requiring monitoring. Overall, the period is characterized by proactive leadership restructuring, with a focus on aligning management with long-term growth strategies, particularly in precision agriculture (AGCO) and retail (CAVA Group).

50 high priority 50 total filings
· daily

US Corporate Board Director Changes SEC Filings — August 03, 2026

The August 3, 2026, digest of USA Board Room Changes reveals a high volume of routine governance transitions, punctuated by a few high-impact CEO successions and strategic board appointments. The most critical development is Danaher's appointment of Julie Sawyer Montgomery as President and CEO, a move that signals strong internal talent development and continuity, backed by her track record of doubling the Diagnostics platform's revenue and tripling its operating profit. A notable pattern is the significant number of Invesco-affiliated funds (11 filings) executing a coordinated, low-materiality board replacement of Jordan Krugman with Matthew Casaccia, indicating a centralized governance restructuring. While most changes are neutral, several appointments bring deep industry expertise, such as the former CEO of Devon Energy joining OGE Energy's board and a former KPMG Global Head of Advisory joining United Community Banks. The digest also flags a few higher-risk events, including the sudden removal of Amaze Holdings' Chairman and CEO and the resignation of two board members from Eikon Therapeutics, which may signal strategic shifts. Overall, the period is characterized by planned successions and board refreshment, with limited negative insider activity or financial guidance changes directly tied to these personnel moves.

50 high priority 50 total filings
· daily

USA Insider Trading Pulse — August 03, 2026

The August 3, 2026 insider trading pulse reveals a market with sharp divergences in management conviction. While a cluster of positive insider buying from bank and telecom executives signals confidence in undervalued financial and defensive sectors, the day's most significant dollar-volume activity is dominated by large-scale, high-conviction insider selling. The CEO of PACCAR executed a $6.78M sale, and a director at Butterfly Network cashed out $12.7M, creating strong bearish signals for industrials and med-tech. A notable pattern of equity awards and option exercises at L3HARRIS and Zhibao Technology suggests a focus on long-term retention rather than immediate cash-out. The data shows a clear bifurcation: insiders are buying value-oriented financials and telecoms while aggressively selling into strength in industrials and growth tech, pointing to a potential rotation in investor sentiment.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — August 03, 2026

This USA M&A digest covers 16 filings, revealing a bifurcated market where strategic, well-capitalized acquirers (Brookfield, Teleflex, Esquire Financial) are executing transformative deals, while distressed situations (Sleep Number, Light Across) highlight the risks of forced sales and dilutive structures. Key period-over-period trends show a divergence in financial health: ONEOK reported strong operational growth (net income +13% YoY), whereas the Light Across acquisition target saw revenue collapse to zero and losses triple. Insider activity is limited but notable, with Bluerock's SPAC deal including insider PIPE investment from Yellow.ai founders, signaling confidence. Forward-looking guidance is a critical catalyst, with Teleflex set to provide updated 2026 guidance on August 6, and ONEOK raising its full-year outlook. Capital allocation is a central theme, with Teleflex planning a $1B buyback post-divestiture, contrasting with Sleep Number's zero recovery for equity holders. The most critical development is the completion of Brookfield's acquisition of Oaktree, creating a $365B credit platform, and Sleep Number's Chapter 11 asset sale, which serves as a cautionary tale for retail investors. A portfolio-level pattern is the rise of SPACs targeting AI and critical minerals (Bluerock/Yellow.ai, Newbridge/Startech, Freedom Metals), indicating sustained appetite for high-growth tech and resource deals despite market volatility.

16 high priority 16 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 03, 2026

This morning's filings reveal a market bifurcated between aggressive capital deployment and significant distress. M&A activity dominates, with Atkore's $3.8B acquisition by Prysmian and Arcosa's $150/share cash deal highlighting premium takeouts, while Skyworks' merger with Qorvo signals consolidation in semis. Financial results are mixed: Japanese banks (Mizuho, MUFG, Nomura) show strong momentum, but EchoStar's going concern doubt and Braskem's potential judicial reorganization present serious red flags. Insider activity is limited to routine transactions, but capital returns are notable, with MUFG and TotalEnergies raising dividends. The SPAC pipeline is active with three new IPOs, though dilution risks are flagged. Key themes include a semiconductor/tech focus in 13F filings, a shift toward US listings (Flutter delisting from LSE), and aggressive expansion in AI infrastructure despite profitability concerns (Solowin).

16 high priority 34 medium 50 total filings
· daily

VA Healthcare & Services Contracts — August 02, 2026

This digest covers 9 contracts totaling $6.77 billion, all awarded by the Department of Veterans Affairs (VA) to a single contractor—UnitedHealth Group's Optum Public Sector Solutions—between July 31 and August 2, 2026. The contracts are exclusively civilian (0% defense-related) and consist of firm-fixed-price delivery orders for managed healthcare services, each with an unusually short one-month performance period (April, May, or June 2026). The aggregate value is massive, but the concentration in a single contractor and the lack of multi-year options or extensions create a mixed signal: bullish for UnitedHealth's near-term revenue but neutral-to-bearish for revenue visibility and execution risk. The highest-conviction signal is the two contracts rated 'bullish' ($918.98M and $918.47M), indicating strong competitive wins, but the remaining seven 'neutral' contracts underscore the risk that these are one-time bridge orders rather than recurring programs. Key watch item: whether the VA issues follow-on orders or extensions beyond June 2026, which would validate a longer-term relationship and improve revenue durability.

9 total filings
· daily

New Federal Contractors — August 02, 2026

This digest of 10 contracts totaling $7.19 billion reveals an extraordinary concentration of awards to UnitedHealth Group's Optum Public Sector Solutions, which captured 9 of 10 contracts worth $6.77 billion from the Department of Veterans Affairs. These are all short-duration, firm-fixed-price delivery orders for managed healthcare services, each spanning a single month (April, May, or June 2026), creating a pattern of high-value, non-recurring revenue with limited forward visibility. The sole defense-related contract is a historical CACI award from 2013, making this digest overwhelmingly civilian-focused. The highest-conviction signal is the bullish competitive win for UnitedHealth Group across multiple VA awards, but the key risk is the extreme concentration of revenue in one-month performance periods, which introduces execution and cash flow uncertainty.

10 total filings
· daily

Significant Contract Modifications ($10M+) — August 02, 2026

This digest of 11 government contracts, totaling $7.19 billion, reveals an extreme concentration of spending: 10 of 11 awards (99.99% of total value) went to UnitedHealth Group’s Optum Public Sector Solutions for single-month, firm-fixed-price managed healthcare delivery orders from the Department of Veterans Affairs. The aggregate $6.77 billion in VA obligations to Optum, all awarded on the same day for performance in April, May, and June 2026, suggests a massive, short-term bridge funding mechanism rather than a multi-year program, creating high revenue visibility for Q2 2026 but zero visibility beyond. The lone defense-related contract is a small, non-material $424K Lockheed Martin flight training award from NOAA, making this a purely civilian-sector story. The highest-conviction signal is the bullish concentration of competitive wins by Optum, but the key risk is the lack of options or extensions, implying a potential cliff in federal healthcare revenue for UnitedHealth Group after June 2026.

11 total filings
· daily

Contract Deobligations Alert — August 02, 2026

This digest covers $7.19 billion in contract obligations, overwhelmingly concentrated in the civilian sector (10 of 11 awards) with only one defense-related contract. The dominant theme is the Department of Veterans Affairs awarding a series of nine, single-month, firm-fixed-price delivery orders to UnitedHealth Group's Optum Public Sector Solutions, totaling approximately $6.77 billion for managed healthcare services in April, May, and June 2026. The highest-conviction signal is the sheer scale and concentration of these awards, which provide immediate, lumpy revenue for UnitedHealth but carry significant execution risk due to the compressed performance periods and zero outlays to date. A key risk is the lack of multi-year visibility, as these appear to be short-term bridge orders rather than a recurring program, making revenue sustainability uncertain.

11 total filings